Auto Amazon Links: No products found.
Researchers have highlighted the need for further testing of their findings within a larger and more varied population to confirm their robustness. Additionally, they emphasized the importance of conducting more studies to compare this diagnostic approach against other conditions that also involve hormonal imbalances, in order to more accurately distinguish endometriosis.
Endometriosis is primarily influenced by female hormones such as estrogen and progesterone, which are associated with the menstrual cycle. However, there has been limited investigation into the involvement of androgens, including testosterone, in the condition. In their study, scientists measured hormone levels in the blood of 159 women with confirmed endometriosis and compared them to 57 women without the disease. They identified a unique hormonal profile in those affected, with elevated levels of certain androgens.
This distinct hormonal fingerprint enabled researchers to differentiate between individuals with and without endometriosis, successfully identifying over 95% of the patients with the condition. The team now aims to collaborate with industry partners to create a diagnostic blood test based on these findings. Meanwhile, other groups are exploring alternative diagnostic methods such as innovative scanning techniques and saliva tests.
The collaboration included scientists from the universities of Liverpool, Glasgow, and Birmingham. Dr. Douglas Gibson, the study’s principal investigator at the University of Edinburgh’s Centre for Reproductive Health, remarked, “These findings mark a significant breakthrough in our understanding of endometriosis. Traditionally seen as an oestrogen-driven disorder, our research challenges this view by showing different androgen levels in the condition. We are optimistic that this new insight will lead to earlier diagnosis and the development of innovative new treatments for those affected by endometriosis.” Dr. Susan Bodie from Edinburgh Innovations, the university’s commercialization arm, described the discovery as addressing an “important unmet need in the field of women’s health” and encouraged potential partners to assist in developing the diagnostic technology. Emma Cox, chief executive of Endometriosis UK, referred to a reliable, non-surgical test for the condition as “much needed” and “long-awaited,” describing the new research as “promising.” She added that this could potentially reduce the time taken to diagnose endometriosis to a few months but stressed the importance of larger trials to validate the results, stating, “This is exactly why investment in endometriosis research matters – and why we will be following the progress of this research with interest.
Read the full article from The BBC here: Read More
Auto Amazon Links: No products found.